Joint final report of eortc 26951 and rtog 9402: phase iii trials with procarbazine, lomustine, and vincristine chemotherapy for anaplastic oligodendroglial tumors

HIGHLIGHTS

• who: Andrew B. Lassman and colleagues from the Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY , Herbert Irving Comprehensive Cancer Center, New York, NY , NewYork-Presbyterian Hospital, New York, NY , AP-HP, Sorbonne Université, Hôpitaux Universitaires La Pitié Salpêtrière, Charles Foix, Service de Neurologie, Paris, France , NRG Oncology Statistics and Data Management Center, Philadelphia, PA have published the Article: Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors, in the Journal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.